The expression status of miR-208a-5p was not significantly associated with clinicopathological parameters of BrCa, including tumor size, lymph node metastasis, distant metastasis, ER, PR, Her2, P53, and Ki67 status by using χ2 test analysis (Additional file 1: Table S1). This evidence concerns the gene TP53 and invasive breast carcinoma.